The non-pvc iv bags market size has grown rapidly in recent years. It will grow from $2.28 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing hospital admissions requiring IV therapy, rising use of infusion-based drug delivery, expansion of chemotherapy treatments, growing awareness of PVC-related health risks, increased use of sterile fluid delivery systems.
The non-pvc iv bags market size is expected to see rapid growth in the next few years. It will grow to $3.8 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for sustainable medical consumables, rising adoption of preservative-free IV solutions, expansion of targeted drug delivery therapies, growing investments in advanced infusion packaging, increasing regulatory focus on material safety. Major trends in the forecast period include increasing adoption of pvc-free medical packaging, rising demand for multi-chamber iv bags, growing use of chemically stable polymer materials, expansion of ready-to-use iv solutions, enhanced focus on drug compatibility.
The increasing patient traffic within healthcare settings is expected to drive the growth of the non-PVC IV bags market in the future. Patient traffic refers to the volume of patients seeking medical care or services within a healthcare facility, such as a hospital, clinic, or doctor's office. There is a higher demand for healthcare services and changes in healthcare policies or insurance coverage. Non-PVC IV bags are needed for patients due to concerns about the potential leaching of harmful chemicals from PVC materials into intravenous fluids, minimizing the risk of patient exposure to toxins. For instance, in January 2024, a report published by the National Health Service (NHS), a UK-based publicly funded healthcare system, stated that 1.63 million patients initiated treatment, and over 2.3 million diagnostic tests were conducted in November 2023. This maintained significant pressure on emergency departments nationwide, with more than 2.1 million accident and emergency (A&E) visits and over 547,000 emergency admissions occurring in December 2023. Therefore, the increasing patient traffic within healthcare settings is driving the growth of the non-PVC IV bags market.
Major players in the non-PVC IV bags market are focusing on developing innovative solutions, such as polyolefin shrink films, to improve safety, sustainability, and compatibility with various IV solutions. Polyolefin shrink films are durable, flexible, and transparent packaging materials that are commonly used for secure, tamper-resistant wrapping in industries such as food, consumer goods, electronics, and pharmaceuticals. Their non-toxic properties and high puncture resistance make them suitable for a wide range of temperature conditions. For example, in February 2024, Innovia Films, a UK-based manufacturer of biaxially-oriented polypropylene film, introduced RayoFloat white APO. This floatable, low-density polyolefin shrink film is designed to protect light-sensitive products. Its key features include easy label detachment during PET recycling, which helps produce high-quality PET flakes for food-grade use. The film's opaque nature offers light-blocking benefits, making it ideal for products like dairy, nutritional, and cosmetics. Moreover, it supports sustainability with up to 20% post-industrial recycled content and complies with the EU’s Packaging and Packaging Waste Regulation (PPWR).
In November 2023, Prange Group, a Germany-based company focused on sales and marketing of pharmaceuticals, and Adragos Pharma, a Germany-based contract development and manufacturing organization (CDMO), acquired Fresenius Kabi’s sterile pharmaceutical production site for an undisclosed amount. As a result of the acquisition, the company aims to expand its existing production network in Europe, North America, and Japan. Through this transaction, Fresenius Kabi will enter into a long-term supply agreement for products manufactured at the site. Fresenius Kabi is a Germany-based manufacturer of non-PVC IV bags.
Major companies operating in the non-pvc iv bags market are Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton Dickinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, ICU Medical Inc., JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Angiplast Pvt. Ltd., Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH, Sealed Air Corporation, Kraton Corporation.
North America was the largest region in the non-PVC IV bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-pvc iv bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-pvc iv bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the non-PVC IV bags market by increasing costs of imported polymer resins, specialty films, sterilization materials, and automated filling equipment. Healthcare suppliers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented IV bag manufacturing. These tariffs are increasing production costs and procurement prices for hospitals. However, they are also supporting local polymer sourcing, domestic IV bag manufacturing expansion, and innovation in cost-efficient and sustainable infusion packaging solutions.
The non-pvc iv bags market research report is one of a series of new reports that provides non-pvc iv bags market statistics, including non-pvc iv bags industry global market size, regional shares, competitors with a non-pvc iv bags market share, detailed non-pvc iv bags market segments, market trends and opportunities, and any further data you may need to thrive in the non-pvc iv bags industry. This non-pvc iv bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Non-PVC IV bags are intravenous bags that do not contain polyvinyl chloride (PVC) and are used in healthcare settings to administer fluids, medications, and nutrients directly into a person's vein. These bags are commonly used in hospitals and emergency medical services due to their resistance to chemicals, heat, and UV light, which ensures the quality and stability of IV fluids.
The primary types of non-PVC IV bags are single-chamber and multi-chamber. Single-chamber non-PVC IV bags contain only one compartment and are made from materials other than PVC, such as ethylene vinyl acetate, polypropylene, copolyester ether, and others. They can contain both frozen and liquid mixtures for various applications, including chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection, and more. These bags are utilized by various end-user industries, including hospitals, clinics, emergency service centers, ambulatory surgical centers, and others.
The non-PVC IV bags market consists of sales of sterilizable IV film or bag, IV tubing, and infusion administration sets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The non-pvc iv bags market size is expected to see rapid growth in the next few years. It will grow to $3.8 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for sustainable medical consumables, rising adoption of preservative-free IV solutions, expansion of targeted drug delivery therapies, growing investments in advanced infusion packaging, increasing regulatory focus on material safety. Major trends in the forecast period include increasing adoption of pvc-free medical packaging, rising demand for multi-chamber iv bags, growing use of chemically stable polymer materials, expansion of ready-to-use iv solutions, enhanced focus on drug compatibility.
The increasing patient traffic within healthcare settings is expected to drive the growth of the non-PVC IV bags market in the future. Patient traffic refers to the volume of patients seeking medical care or services within a healthcare facility, such as a hospital, clinic, or doctor's office. There is a higher demand for healthcare services and changes in healthcare policies or insurance coverage. Non-PVC IV bags are needed for patients due to concerns about the potential leaching of harmful chemicals from PVC materials into intravenous fluids, minimizing the risk of patient exposure to toxins. For instance, in January 2024, a report published by the National Health Service (NHS), a UK-based publicly funded healthcare system, stated that 1.63 million patients initiated treatment, and over 2.3 million diagnostic tests were conducted in November 2023. This maintained significant pressure on emergency departments nationwide, with more than 2.1 million accident and emergency (A&E) visits and over 547,000 emergency admissions occurring in December 2023. Therefore, the increasing patient traffic within healthcare settings is driving the growth of the non-PVC IV bags market.
Major players in the non-PVC IV bags market are focusing on developing innovative solutions, such as polyolefin shrink films, to improve safety, sustainability, and compatibility with various IV solutions. Polyolefin shrink films are durable, flexible, and transparent packaging materials that are commonly used for secure, tamper-resistant wrapping in industries such as food, consumer goods, electronics, and pharmaceuticals. Their non-toxic properties and high puncture resistance make them suitable for a wide range of temperature conditions. For example, in February 2024, Innovia Films, a UK-based manufacturer of biaxially-oriented polypropylene film, introduced RayoFloat white APO. This floatable, low-density polyolefin shrink film is designed to protect light-sensitive products. Its key features include easy label detachment during PET recycling, which helps produce high-quality PET flakes for food-grade use. The film's opaque nature offers light-blocking benefits, making it ideal for products like dairy, nutritional, and cosmetics. Moreover, it supports sustainability with up to 20% post-industrial recycled content and complies with the EU’s Packaging and Packaging Waste Regulation (PPWR).
In November 2023, Prange Group, a Germany-based company focused on sales and marketing of pharmaceuticals, and Adragos Pharma, a Germany-based contract development and manufacturing organization (CDMO), acquired Fresenius Kabi’s sterile pharmaceutical production site for an undisclosed amount. As a result of the acquisition, the company aims to expand its existing production network in Europe, North America, and Japan. Through this transaction, Fresenius Kabi will enter into a long-term supply agreement for products manufactured at the site. Fresenius Kabi is a Germany-based manufacturer of non-PVC IV bags.
Major companies operating in the non-pvc iv bags market are Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton Dickinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, ICU Medical Inc., JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Angiplast Pvt. Ltd., Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH, Sealed Air Corporation, Kraton Corporation.
North America was the largest region in the non-PVC IV bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-pvc iv bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-pvc iv bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the non-PVC IV bags market by increasing costs of imported polymer resins, specialty films, sterilization materials, and automated filling equipment. Healthcare suppliers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented IV bag manufacturing. These tariffs are increasing production costs and procurement prices for hospitals. However, they are also supporting local polymer sourcing, domestic IV bag manufacturing expansion, and innovation in cost-efficient and sustainable infusion packaging solutions.
The non-pvc iv bags market research report is one of a series of new reports that provides non-pvc iv bags market statistics, including non-pvc iv bags industry global market size, regional shares, competitors with a non-pvc iv bags market share, detailed non-pvc iv bags market segments, market trends and opportunities, and any further data you may need to thrive in the non-pvc iv bags industry. This non-pvc iv bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Non-PVC IV bags are intravenous bags that do not contain polyvinyl chloride (PVC) and are used in healthcare settings to administer fluids, medications, and nutrients directly into a person's vein. These bags are commonly used in hospitals and emergency medical services due to their resistance to chemicals, heat, and UV light, which ensures the quality and stability of IV fluids.
The primary types of non-PVC IV bags are single-chamber and multi-chamber. Single-chamber non-PVC IV bags contain only one compartment and are made from materials other than PVC, such as ethylene vinyl acetate, polypropylene, copolyester ether, and others. They can contain both frozen and liquid mixtures for various applications, including chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection, and more. These bags are utilized by various end-user industries, including hospitals, clinics, emergency service centers, ambulatory surgical centers, and others.
The non-PVC IV bags market consists of sales of sterilizable IV film or bag, IV tubing, and infusion administration sets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Non-PVC IV Bags Market Characteristics
3. Non-PVC IV Bags Market Supply Chain Analysis
4. Global Non-PVC IV Bags Market Trends and Strategies
5. Non-PVC IV Bags Market Analysis of End Use Industries
7. Global Non-PVC IV Bags Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Non-PVC IV Bags Total Addressable Market (TAM) Analysis for the Market
9. Non-PVC IV Bags Market Segmentation
10. Non-PVC IV Bags Market Regional and Country Analysis
11. Asia-Pacific Non-PVC IV Bags Market
12. China Non-PVC IV Bags Market
13. India Non-PVC IV Bags Market
14. Japan Non-PVC IV Bags Market
15. Australia Non-PVC IV Bags Market
16. Indonesia Non-PVC IV Bags Market
17. South Korea Non-PVC IV Bags Market
18. Taiwan Non-PVC IV Bags Market
19. South East Asia Non-PVC IV Bags Market
20. Western Europe Non-PVC IV Bags Market
21. UK Non-PVC IV Bags Market
22. Germany Non-PVC IV Bags Market
23. France Non-PVC IV Bags Market
24. Italy Non-PVC IV Bags Market
25. Spain Non-PVC IV Bags Market
26. Eastern Europe Non-PVC IV Bags Market
27. Russia Non-PVC IV Bags Market
28. North America Non-PVC IV Bags Market
29. USA Non-PVC IV Bags Market
30. Canada Non-PVC IV Bags Market
31. South America Non-PVC IV Bags Market
32. Brazil Non-PVC IV Bags Market
33. Middle East Non-PVC IV Bags Market
34. Africa Non-PVC IV Bags Market
36. Non-PVC IV Bags Market Competitive Landscape and Company Profiles
37. Non-PVC IV Bags Market Other Major and Innovative Companies
40. Non-PVC IV Bags Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Non-PVC IV Bags Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses non-pvc iv bags market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for non-pvc iv bags? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-pvc iv bags market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Single Chamber; Multi Chamber2) By Material: Ethylene Vinyl Acetate; Polypropylene; Copolyester Ether; Other Materials
3) By Content: Ready-To-Use Sterile Fluids; Liquid Mixture
4) By Application: Chemotherapy; Targeted Drug Delivery; Glucose Injection; Sodium Chloride Solution; Electrolyte Injection; Nutrient Injection; Other Applications
5) By End User: Hospitals; Clinics; Emergency Service Centers; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Single Chamber: Standard Single Chamber Iv Bags; Flexible Single Chamber Iv Bags2) By Multi Chamber: Dual Chamber Iv Bags; Triple Chamber Iv Bags; Multi-Camber Iv Bags (More Than Three Chambers)
Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; Abbott Laboratories; Medline Industries LP; Becton Dickinson and Company; Otsuka Pharmaceutical Co. Ltd.; Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Grifols S.A.; Terumo Corporation; Nipro Corporation; ICU Medical Inc.; JW Life Science; Jiangxi Sanxin Medtec Co. Ltd.; Angiplast Pvt. Ltd.; Technoflex SA; Medi Pharma Plan Co. Ltd.; Bausch Advanced Technologies Inc.; PolyCine GmbH; Sealed Air Corporation; Kraton Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Non-PVC IV Bags market report include:- Cardinal Health Inc.
- Pfizer Inc.
- Abbott Laboratories
- Medline Industries LP
- Becton Dickinson and Company
- Otsuka Pharmaceutical Co. Ltd.
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Grifols S.A.
- Terumo Corporation
- Nipro Corporation
- ICU Medical Inc.
- JW Life Science
- Jiangxi Sanxin Medtec Co. Ltd.
- Angiplast Pvt. Ltd.
- Technoflex SA
- Medi Pharma Plan Co. Ltd.
- Bausch Advanced Technologies Inc.
- PolyCine GmbH
- Sealed Air Corporation
- Kraton Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.52 Billion |
| Forecasted Market Value ( USD | $ 3.8 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
